文献速递流行病学与生物统计真实世界研究与卫生经济

甲状腺癌筛查:美国预防服务工作组更新版证据报告与系统综述

Screening for Thyroid Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
PubMed 文献 · JAMA · 2017-01-01

该系统综述检索1966年1月至2016年1月文献并主动监测至2016年12月,纳入67项研究,评估无症状成人甲状腺癌筛查与早期治疗的利益与危害。未发现直接评估筛查获益的高质量研究;筛查或超声引导下细针穿刺未提示严重危害;手术永久性甲状旁腺功能减退发生率为每100例甲状腺切除术2.12至5.93例(95%CI),永久性喉返神经麻痹为每100例手术0.99至2.13例(95%CI)。

要点

  • 未发现直接评估甲状腺癌筛查获益的 fair- to good-quality 研究。
  • 颈部触诊在2项研究(n=354)中对检出甲状腺结节不敏感。
  • 手术永久性甲状旁腺功能减退为每100例甲状腺切除术2.12至5.93例(95%CI)。

核心结论

  • 尽管采用高风险超声特征联合细针穿刺随访细胞学可识别甲状腺癌,但尚不清楚基于人群或针对性筛查能否降低死亡率或改善重要患者健康结局。
  • 筛查发现惰性甲状腺癌并治疗这些过度诊断的癌症可能增加患者危害风险。

研究设计与样本

  • 系统综述检索MEDLINE、PubMed和Cochrane对照试验中心注册库,纳入1966年1月至2016年1月发表的英文研究,主动监测至2016年12月;由两名评价者独立评估文献并提取 fair- 或 good-quality 研究数据,采用随机效应Meta分析合并手术危害。
  • 共筛选10424篇摘要,审阅707篇全文,最终纳入67项研究。

主要发现

  • 无 fair- to good-quality 研究直接评估甲状腺癌筛查的获益。
  • 2项研究(n=354)显示颈部触诊对检出甲状腺结节不敏感。
  • 2项方法学受限的研究(n=243)显示,所选高风险超声特征的组合对甲状腺恶性肿瘤具有特异性。
  • 3项研究(n=5894)直接评估甲状腺癌筛查的危害,均未提示筛查或超声引导下细针穿刺造成任何严重危害。
  • 无筛查研究直接评估过度诊断风险;2项观察性研究(n=39211)纳入接受治疗的分化型甲状腺癌患者与未手术或监测者,但未校正混杂因素,故无法确定早期或立即治疗相较于延迟或不手术能否改善患者结局。

关键数值与推荐

  • 颈部触诊在2项研究(n=354)中对检出甲状腺结节不敏感。
  • 2项方法学受限的研究(n=243)中,所选高风险超声特征的组合对甲状腺恶性肿瘤具有特异性。
  • 3项研究(n=5894)未提示筛查或超声引导下细针穿刺造成任何严重危害。
  • 36项研究(n=43295)合并显示,永久性甲状旁腺功能减退发生率为每100例甲状腺切除术2.12至5.93例(95%CI),永久性喉返神经麻痹为每100例手术0.99至2.13例(95%CI)。
  • 16项研究(n=291796)显示,放射性碘治疗与第二原发恶性肿瘤风险小幅增加及唾液腺永久性不良反应风险增加相关。

临床怎么用

  • 原文结论未据此给出推荐。

局限性

  • 无 fair- to good-quality 研究直接评估甲状腺癌筛查的获益。
  • 2项评估超声特征的研究方法学受限。
  • 2项观察性研究未校正混杂因素,故无法确定早期或立即治疗相较于延迟或不手术能否改善患者结局。
  • 无筛查研究直接评估过度诊断风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The incidence of detected thyroid cancer cases has been increasing in the United States since 1975. The majority of thyroid cancers are differentiated cancers with excellent prognosis and long-term survival. OBJECTIVE: To systematically review the benefits and harms associated with thyroid cancer screening and treatment of early thyroid cancer in asymptomatic adults to inform the US Preventive Services Task Force. DATA SOURCES: Searches of MEDLINE, PubMed, and the Cochrane Central Register of Controlled Trials for relevant studies published from January 1966 through January 2016, with active surveillance through December 2016. STUDY SELECTION: English-language studies conducted in asymptomatic adult populations. DATA EXTRACTION AND SYNTHESIS: Two reviewers independently appraised the articles and extracted relevant study data from fair- or good-quality studies. Random-effects meta-analyses were conducted to pool surgical harms. MAIN OUTCOMES AND MEASURES: Thyroid cancer morbidity and mortality, test accuracy to detect thyroid nodules or thyroid cancer, and harms resulting from screening (including overdiagnosis) or treatment of thyroid cancer. RESULTS: Of 10 424 abstracts, 707 full-text articles were reviewed, and 67 studies were included for this review. No fair- to good-quality studies directly examined the benefit of thyroid cancer screening. In 2 studies (n = 354), neck palpation was not sensitive to detect thyroid nodules. In 2 methodologically limited studies (n = 243), a combination of selected high-risk sonographic features was specific for thyroid malignancy. Three studies (n = 5894) directly addressed the harms of thyroid cancer screening, none of which suggested any serious harms from screening or ultrasound-guided fine-needle aspiration. No screening studies directly examined the risk of overdiagnosis. Two observational studies (n = 39 211) included cohorts of persons treated for well-differentiated thyroid cancer and persons with no surgery or surveillance; however, these studies did not adjust for confounders and therefore were not designed to determine if earlier or immediate treatment vs delayed or no surgical treatment improves patient outcomes. Based on 36 studies (n = 43 295), the 95% CI for the rate of surgical harm was 2.12 to 5.93 cases of permanent hypoparathyroidism per 100 thyroidectomies and 0.99 to 2.13 cases of recurrent laryngeal nerve palsy per 100 operations. Based on 16 studies (n = 291 796), treatment of differentiated thyroid cancer with radioactive iodine is associated with a small increase in risk of second primary malignancies and with increased risk of permanent adverse effects on the salivary gland, such as dry mouth. CONCLUSIONS AND RELEVANCE: Although ultrasonography of the neck using high-risk sonographic characteristics plus follow-up cytology from fine-needle aspiration can identify thyroid cancers, it is unclear if population-based or targeted screening can decrease mortality rates or improve important patient health outcomes. Screening that results in the identification of indolent thyroid cancers, and treatment of these overdiagnosed cancers, may increase the risk of patient harms.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Lin JS, Bowles EJA, Williams SB, et al. Screening for Thyroid Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2017. PMID: 28492904. doi:10.1001/jama.2017.0562

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。